Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service

Aim To determine if current guidelines correctly identify patients who will benefit from continuous subcutaneous insulin infusion (CSII) therapy by comparing outcomes between Type 1 diabetic patients with recurrent severe hypoglycaemia (SH) indications with those without; and between patients witho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetic medicine 2005-07, Vol.22 (7), p.842-849
Hauptverfasser:	Rodrigues, I. A. S., Reid, H. A., Ismail, K., Amiel, S. A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Cutaneous Adolescent Adult Biological and medical sciences Child continuous subcutaneous insulin infusion Contraindications Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - drug therapy Diabetes. Impaired glucose tolerance Diabetic Angiopathies - etiology diabetic ketoacidosis Diabetic Ketoacidosis - drug therapy Drug Administration Schedule Endocrine pancreas. Apud cells (diseases) Endocrinopathies Female Glycated Hemoglobin A - analysis Humans hypoglycaemia Hypoglycemia - drug therapy Hypoglycemic Agents - administration & dosage indications Insulin - administration & dosage Insulin Infusion Systems Male Medical sciences Middle Aged Patient Care Team Quality of Life Recurrence Risk Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!